Raleigh-based Sprout Pharmaceuticals has received FDA approval to market its ADDYI (flibanserin) pill to treat hypoactive sexual desire disorder in premenopausal women. CEO Cindy Whitehead elaborates on her new small pharma company's efforts to p McClatchy
Raleigh-based Sprout Pharmaceuticals has received FDA approval to market its ADDYI (flibanserin) pill to treat hypoactive sexual desire disorder in premenopausal women. CEO Cindy Whitehead elaborates on her new small pharma company's efforts to p McClatchy

Drug execs behind female libido pill have run afoul of FDA

August 14, 2015 12:51 PM